More From The Market Online
Immutep obtains encouraging disease-free survival in phase II sarcoma trial
Immutep has unveiled new data from the investigator-initiated EFTISARC-NEO Phase II study evaluating radiotherapy before surgery.
- Colin Sandell-Hay
- 2 mins
- 19 November 2026 10:50 (AEDT)
Xenitra signs JD Health strategic Chinese agreement targeting $100m in sales
Xenitra subsidiary Shengdi Pharmaceutical has entered into a three-year strategic agreement with China’s largest online healthcare…
- Colin Sandell-Hay
- 3 mins
- 18 November 2026 10:55 (AEDT)
Racura Oncology receives positive results in study of RC110 and RC220
Racura Oncology has obtained positive results from a study into RC220, the company’s proprietary formulation of…
- Colin Sandell-Hay
- 3 mins
- 17 November 2026 10:46 (AEDT)
TruScreen continues global growth with product registration in Kenya
TruScreen Group has received product registration in the Republic of Kenya, a priority market for cervical…
- Colin Sandell-Hay
- 2 mins
- 16 November 2026 10:12 (AEDT)
